ArticleArthritis research & therapy2022

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.

Cindy Orvain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.